tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Aspira Women’s Health Appoints Jane Pine Wood to Board

Story Highlights
  • Aspira Women’s Health appointed Jane Pine Wood to its Board on July 11, 2025.
  • Ms. Wood’s extensive healthcare legal experience is expected to bolster Aspira’s growth and industry position.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Aspira Women’s Health Appoints Jane Pine Wood to Board

Elevate Your Investing Strategy:

Aspira Women’s Health ( (AWHL) ) has shared an announcement.

On July 11, 2025, Aspira Women’s Health appointed Jane Pine Wood to its Board of Directors. Ms. Wood brings over 38 years of legal experience in healthcare, having worked with a diverse range of healthcare providers. Her expertise is expected to support Aspira’s growth and drive advancements in women’s healthcare. This strategic appointment is likely to enhance the company’s operations and strengthen its position in the women’s health diagnostics industry.

The most recent analyst rating on (AWHL) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Aspira Women’s Health stock, see the AWHL Stock Forecast page.

Spark’s Take on AWHL Stock

According to Spark, TipRanks’ AI Analyst, AWHL is a Underperform.

The overall score is primarily driven by the poor financial performance, including negative equity and cash flow challenges. Technical analysis shows potential overbought conditions, while the valuation remains unattractive due to negative earnings. The recent termination of a significant contract further exacerbates concerns about the company’s operational and strategic stability.

To see Spark’s full report on AWHL stock, click here.

More about Aspira Women’s Health

Aspira Women’s Health Inc. is an AI-enhanced bio-analytical company focused on developing noninvasive tests for gynecologic disease diagnostics and management. The company offers OvaWatch and Ova1Plus tests under the OvaSuite portfolio, which aid in detecting ovarian cancer risk. Aspira is also working on expanding its test pipeline to include diagnostics for endometriosis.

Average Trading Volume: 354,430

Technical Sentiment Signal: Sell

Current Market Cap: $5.86M

For an in-depth examination of AWHL stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1